Nigel C. Jones

17.1k citations

180 papers · 10.6k · 3 hit papers · h-index 48

Impact in

Endocrinology, Diabetes and Metabolism top 0.2%
- Diabetes Treatment and Management
- Diabetes Management and Research
Psychiatry and Mental health top 0.5%
- Epilepsy research and treatment

Papers in

Molecular Biology 40
- Mitochondrial Function and Pathology 8
Cellular and Molecular Neuroscience 40
- Neuroscience and Neuropharmacology Research 38

Co-authors: Terence J. O’Brien (99 shared papers)Steven E. Kahn (6 shared papers)Giancarlo Viberti (6 shared papers)William H. Herman (5 shared papers)Steven M. Haffner (5 shared papers)Rury R. Holman (5 shared papers)Bernard Zinman (5 shared papers)John M. Lachin (5 shared papers)
Journals: Epilepsia (24 papers)Neurobiology of Disease (11 papers)PLoS ONE (8 papers)Epilepsy Research (5 papers)Psychoneuroendocrinology (5 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Nigel C. Jones

172 papers receiving 10.2k citations

Nigel C. Jones's Hit Papers

align trajectories log scale

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial 2009 · 1.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 The Lancet
2007 New England Journal of Medicine
2006 New England Journal of Medicine

Peers

Countries citing papers authored by Nigel C. Jones

Since Specialization

Citations

This map shows the geographic impact of Nigel C. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel C. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel C. Jones more than expected).

Fields of papers citing papers by Nigel C. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel C. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel C. Jones. The network helps show where Nigel C. Jones may publish in the future.

Co-authors

The 25 scholars most cited alongside Nigel C. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nigel C. Jones Line = papers co-authored together Nigel C. Jones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy New England Journal of Medicine ·Steven E. Kahn, Steven M. Haffner, Mark Heise, William H. Herman, Rury R. Holman, Nigel C. Jones, Barbara G. Kravitz, John M. Lachin, Mark O’Neill, Bernard Zinman, Giancarlo Viberti Hit paper breakdown →	2006	2299
2	Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial The Lancet ·Philip Home, Stuart Pocock, Henning Beck‐Nielsen, Paula Curtis, Ramón Gomis, M Hanefeld, Nigel C. Jones, Michel Komajda, John J.V. McMurray Hit paper breakdown →	2009	1060
3	Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis New England Journal of Medicine ·Philip Home, Stuart Pocock, Henning Beck‐Nielsen, Ramón Gomis, M Hanefeld, Nigel C. Jones, Michel Komajda, John J.V. McMurray Hit paper breakdown →	2007	583
4	A Diabetes Outcome Progression Trial (ADOPT) Diabetes Care ·Giancarlo Viberti, Steven E. Kahn, Douglas A. Greene, William H. Herman, Bernard Zinman, Rury R. Holman, Steven M. Haffner, Daniel Levy, John M. Lachin, Rhona A. Berry, Mark Heise, Nigel C. Jones, Martin I. Freed	2002	202
5	NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness PLoS ONE ·Tahir Hakami, Nigel C. Jones, E.A. Tolmacheva, Julien Gaudias, Joseph Chaumont, Michael Salzberg, Terence J. O’Brien, Didier Pinault	2009	199
6	Elevated anxiety and depressive-like behavior in a rat model of genetic generalized epilepsy suggesting common causation Experimental Neurology ·Nigel C. Jones, Michael Salzberg, Gaurav Kumar, Abbie Couper, Margaret J. Morris, Terence J. O’Brien	2007	180
7	Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients Obesity Research ·D. Carey, Gary Cowin, Graham J. Galloway, Nigel C. Jones, Jackie C. Richards, Nandita Biswas, David M. Doddrell	2002	178
8	T-Type Calcium Channel Blockers That Attenuate Thalamic Burst Firing and Suppress Absence Seizures Science Translational Medicine ·Elizabeth Tringham, Kim L. Powell, Stuart M. Cain, Kristy G. Kuplast, Janette Mezeyova, Manjula Weerapura, Cyrus Eduljee, Xinpo Jiang, Paula Marincola Smith, Jerrie-Lynn Morrison, Nigel C. Jones, Emma L. Braine, Gil S. Rind, Molly Fee-Maki, David Parker, Hassan Pajouhesh, Manjeet Parmar, Terence J. O’Brien, Terrance P. Snutch	2012	175
9	Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients Neurology ·Slavé Petrovski, Cassandra Szoeke, Nigel C. Jones, Michael Salzberg, Leslie J. Sheffield, Richard Huggins, Terence J. O’Brien	2010	167
10	Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial European Heart Journal ·Michel Komajda, John J.V. McMurray, Henning Beck‐Nielsen, Ramón Gomis, M Hanefeld, S J Pocock, Peter S. Curtis, Nigel C. Jones, P. D. Home	2010	161
11	Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes Diabetes ·Steven E. Kahn, Bernard Zinman, Steven M. Haffner, Mark O’Neill, Barbara G. Kravitz, Dahong Yu, Martin I. Freed, William H. Herman, Rury R. Holman, Nigel C. Jones, John M. Lachin, Giancarlo Viberti, (unknown)	2006	156
12	Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes The Journal of Clinical Endocrinology & Metabolism ·Bernard Zinman, Steven M. Haffner, William H. Herman, Rury R. Holman, John M. Lachin, Barbara G. Kravitz, Gitanjali Paul, Nigel C. Jones, R. Paul Aftring, Giancarlo Viberti, Steven E. Kahn	2009	155
13	Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury Brain ·Sandy R. Shultz, David Wright, Ping Zheng, Ryan Stuchbery, Shijie Liu, Maithili Sashindranath, Robert L. Medcalf, Leigh A. Johnston, Christopher M. Hovens, Nigel C. Jones, Terence J. O’Brien	2015	143
14	Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials Diabetologia ·P. D. Home, Steven E. Kahn, Nigel C. Jones, Drusilla Noronha, Henning Beck‐Nielsen, Giancarlo Viberti	2010	143
15	Early Postnatal Stress Confers Enduring Vulnerability to Limbic Epileptogenesis Epilepsia ·Michael Salzberg, Gaurav Kumar, Laureen Supit, Nigel C. Jones, Margaret J. Morris, Sandra Rees, Terence J. O’Brien	2007	132
16	Experimental Traumatic Brain Injury Induces a Pervasive Hyperanxious Phenotype in Rats Journal of Neurotrauma ·Nigel C. Jones, Lisa Cardamone, John P. Williams, Michael Salzberg, Damian E. Myers, Terence J. O’Brien	2008	114
17	Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau Brain ·Shi-Jie Liu, Ping Zheng, David Wright, Gabi Dezsi, Emma L. Braine, Thanh Thanh L. Nguyen, Niall M. Corcoran, Leigh A. Johnston, Christopher M. Hovens, Jamie N. Mayo, Matthew R. Hudson, Sandy R. Shultz, Nigel C. Jones, Terence J. O’Brien	2016	109
18	Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome? Epilepsia ·Sandy R. Shultz, Lisa Cardamone, Ying R. Liu, R. Edward Hogan, Luigi Maccotta, David Wright, Ping Zheng, Amelia S. Koe, Marie‐Claude Grégoire, John P. Williams, Rodney J. Hicks, Nigel C. Jones, Damian E. Myers, Terence J. O’Brien, Viviane Bouilleret	2013	108
19	Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy Epilepsia ·Gabi Dezsi, Ezgi Öztürk, Davor Stanić, Kim L. Powell, Hal Blumenfeld, Terence J. O’Brien, Nigel C. Jones	2013	100
20	Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE Epilepsia ·Bianca Jupp, John P. Williams, David Binns, Rodney J. Hicks, Lisa Cardamone, Nigel C. Jones, Sandra Rees, Terence J. O’Brien	2012	91

About Nigel C. Jones

Nigel C. Jones is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Psychiatry and Mental health, Neurology and Physiology, having authored 180 papers that have together received 10.6k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (38 papers), Epilepsy research and treatment (29 papers), Traumatic Brain Injury and Neurovascular Disturbances (17 papers), Stress Responses and Cortisol (12 papers), Neural dynamics and brain function (12 papers), Alzheimer's disease research and treatments (10 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Mitochondrial Function and Pathology (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.0k citations), Psychiatry and Mental health (1.4k citations), Cellular and Molecular Neuroscience (1.8k citations), Developmental Neuroscience (344 citations) and Behavioral Neuroscience (298 citations). Nigel C. Jones has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Terence J. O’Brien, Steven E. Kahn, Giancarlo Viberti, William H. Herman, Steven M. Haffner, Rury R. Holman, Bernard Zinman, John M. Lachin, Henning Beck‐Nielsen and Barbara G. Kravitz. Their work appears in journals such as Epilepsia, Neurobiology of Disease, PLoS ONE, Epilepsy Research and Psychoneuroendocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Nigel C. Jones

Impact in

Papers in i

In The Last Decade

Nigel C. Jones

Nigel C. Jones's Hit Papers

Peers

Countries citing papers authored by Nigel C. Jones

Fields of papers citing papers by Nigel C. Jones

All Works

About Nigel C. Jones

Explore authors with similar magnitude of impact

Papers in